All products / DC12273
EMT inhibitor-1
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $950 USDRequest a quote / confirm availability → |
| 250 mg | $1,900 USDRequest a quote / confirm availability → |
| 1 g | $3,800 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
In Vitro EMT inhibitor-1 (C19) is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities, inhibiting cancer cell migration, proliferation, and resistance to doxorubicin in vitro. In Vivo EMT inhibitor-1 (C19) exerts strong antitumor activity in a mouse tumor model. Mechanistically, EMT inhibitor-1 induces GSK3-β–mediated degradation of the Hippo transducer TAZ, through activation of the Hippo kinases Mst/Lats and the tumor suppressor kinase AMPK upstream of the degradation complex.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC12273 |
|---|---|
| Product name | EMT inhibitor-1 |
| CAS | 1638526-21-2 |
| Molecular formula | C12H12Cl2N2O2S |
| Molecular weight | 319.21 |
| Purity | >98% |
| SMILES | OCCCCOc1nsnc1-c1ccc(Cl)c(Cl)c1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — EMT inhibitor-1 (DC12273)